Assura Plc (LON:AGR – Get Free Report) insider Jonathan Murphy sold 104,817 shares of Assura stock in a transaction that occurred on Wednesday, July 12th. The shares were sold at an average price of GBX 46 ($0.59), for a total transaction of £48,215.82 ($62,029.87).
Jonathan Murphy also recently made the following trade(s):
- On Friday, May 5th, Jonathan Murphy bought 294 shares of Assura stock. The stock was purchased at an average price of GBX 51 ($0.66) per share, for a total transaction of £149.94 ($192.90).
Assura Stock Up 1.0 %
Shares of AGR opened at GBX 46.18 ($0.59) on Friday. Assura Plc has a 52 week low of GBX 43.12 ($0.55) and a 52 week high of GBX 71.60 ($0.92). The firm has a market capitalization of £1.37 billion, a P/E ratio of -1,154.50, a P/E/G ratio of 3.60 and a beta of 0.26. The company has a 50-day simple moving average of GBX 48.02 and a 200-day simple moving average of GBX 50.80. The company has a debt-to-equity ratio of 78.90, a quick ratio of 2.84 and a current ratio of 1.95.
Assura Increases Dividend
Wall Street Analyst Weigh In
A number of research firms have issued reports on AGR. Peel Hunt restated a “buy” rating and set a GBX 65 ($0.84) price target on shares of Assura in a report on Tuesday, May 23rd. JPMorgan Chase & Co. restated a “neutral” rating and set a GBX 56 ($0.72) target price on shares of Assura in a research note on Wednesday, May 24th. Shore Capital reaffirmed a “buy” rating on shares of Assura in a research report on Thursday, July 6th. Finally, Barclays reiterated an “overweight” rating and set a GBX 57 ($0.73) price target on shares of Assura in a report on Wednesday, May 24th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Assura presently has a consensus rating of “Moderate Buy” and an average target price of GBX 60.75 ($0.78).
Assura Company Profile
Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.
See Also
- Five stocks we like better than Assura
- Delta Takes Flight: Double-Digit Upside In Sight
- Generac Powers Up as Summer Temperatures Rise
- 3 Reasons Why Rivian Can Continue To Surge Higher
- Despite Breaking Higher, Analysts Remain Cautious HP Inc.
- PepsiCo Can Soar To New Highs In The 2nd Half
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.